CME vs TXMD · P/E 22, rev $3.59B vs rev $1.6M
CME Group Inc (CME) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported TXMD revenue for 2026-06-30 was $1.6M. Net income was $250.0K. TXMD currently screens at market cap $13.7M.
CME currently screens at market cap $91.25B and trailing P/E 21.9. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the CME and TXMD stock pages for the full models.
Not investment advice.